CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Trends Reshaping the Cell and Gene Therapies

Trends Reshaping the Cell and Gene...

Efficiency-driven Digital Therapeutics Reshaping the European Healthcare

Efficiency-driven Digital...

A Patient-Focussed Therapeutic Measure Taking Up the Healthcare Space

A Patient-Focussed Therapeutic...

A Canadian Approach to Commercializing Cell and Gene Therapies

A Canadian Approach to...

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

The Dynamic Commercial Aspects of Life Sciences

The Dynamic Commercial Aspects of...

Trends Reshaping the Cell and Gene Therapies

Trends Reshaping the Cell and Gene...

Efficiency-driven Digital Therapeutics Reshaping the European Healthcare

Efficiency-driven Digital...

A Patient-Focussed Therapeutic Measure Taking Up the Healthcare Space

A Patient-Focussed Therapeutic...

A Canadian Approach to Commercializing Cell and Gene Therapies

A Canadian Approach to...

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

The Dynamic Commercial Aspects of Life Sciences

The Dynamic Commercial Aspects of...

Rocket VR Health Has Got Selected For The Newchip Seed-Stage Global Accelerator Program

Life Sciences Review Life Sciences Review | Monday, August 01, 2022
Tweet

Top applications for Newchip's leading accelerator program include an immersive digital medicines startup.


Fremont, CA: Digital therapeutics can meet patient requirements that have gone unmet by conventional medications and treatments. Companies that can use life sciences technologies to close these gaps together with quicker product development cycles may outperform established life sciences firms.


Rocket VR Health, a digital therapeutics company producing immersive therapy programs for cancer patients and survivors, has been accepted into Newchip's renowned global accelerator program, designed to provide seed-stage founders with all the skills and tools they need to fund, build, and scale their businesses rapidly. With an estimated portfolio of more than 9 billion dollars, the equity-free, entirely digital accelerator has assisted over 1,500 startups from more than 50 countries and 250 locations in raising over 450 million dollars in fundraising.


"Newchip evaluates a vast and diverse number of seed-stage companies from around the globe, selecting only a small percentage to be part of our Seed Accelerator program," says Armando Vera Carvajal, Vice President of Product at Newchip. 


 


"This careful vetting process of both the business model and founders makes us an ideal partner for venture capital investors and other key stakeholders in early-stage startup financings who are looking for promising startups that are beginning to generate traction and revenue. Innovative healthcare technology companies like Rocket VR Health can scale quickly with proper funding and guidance. We are excited for Rocket VR Health and believe they will be well positioned to take advantage of our fast-expanding global ecosystem at Newchip."


Rocket VR Health, a tech firm founded in 2020, is creating various immersive virtual reality (VR) therapeutic packages to enhance the mental health of cancer patients and survivors significantly. Rocket VR Health aims to improve the accessibility, enjoyment, and engagement of cancer patients' mental healthcare. By incorporating tried-and-true clinical procedures into gamified exercises, meditations, and on-demand treatment experiences in stunning 3D natural settings, the firm aims to create the next generation of digital therapies.


Since its inception, the business has put together a top-notch staff of renowned oncologists, Hollywood animators, game designers, and knowledgeable VR technologists. Rocket VR Health is dedicated to advancing cutting-edge research and the use of VR in healthcare, and it is currently collaborating with several renowned oncology organizations.


Weekly Brief

loading
TOP VENDORS
Top 10 Therapeutics Companies – 2022
TOP VENDORS
Top 10 Emerging Therapeutics Companies – 2022
TOP VENDORS
Top 10 Therapeutics Companies – 2022
TOP VENDORS
Top 10 Emerging Therapeutics Companies – 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/rocket-vr-health-has-got-selected-for-the-newchip-seedstage-global-accelerator-program-nwid-926.html